Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Affect Therapeutics

Explore full profile

Using mobile technology to deliver the world's first evidence-based, substance-specific recovery program for methamphetamine and cocaine use disorder

Tysons, United StatesFounded 2020Health Tech & Medtech
Valuation $100–250M Last recorded · 2025
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Affect Therapeutics and the history behind them.

About Affect Therapeutics

Affect Therapeutics is a digital healthcare startup that operates in the addiction recovery sector. The company offers a unique, science-based approach to addiction treatment, using a combination of financial incentives, therapy, and medication to help individuals overcome their addictions. This approach, known as "contingency management," rewards healthy behaviors and encourages the formation of new habits, leading to better recovery outcomes.

Affect Therapeutics serves individuals struggling with addiction, providing them with a private, fully digital, and always accessible platform for treatment. All appointments are conducted via secure video conference, eliminating the need for physical travel to a rehab clinic. This convenience and privacy make the service appealing to those who may be hesitant to seek help in traditional settings.

In addition to treatment, Affect Therapeutics also offers support in other areas of life that can impact recovery, such as job hunting, finding a better place to live, or managing bills. This holistic approach recognizes that getting sober is not just about quitting substances, but also about improving one's overall life circumstances.

The company's business model is likely based on a subscription or fee-for-service model, where clients pay for the treatment and support services they receive. This revenue is then used to fund the company's operations and growth.

In summary, Affect Therapeutics is a digital healthcare startup that provides a comprehensive, science-based, and convenient approach to addiction recovery, helping individuals not only overcome their addictions but also improve their overall life circumstances.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2020
Headquarters
Tysons, United States
Employees
158
Open positions
None listed
Dealroom signal
91.5/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Addiction, Hard Tech
Technology
Mobile app
Client focus
b2c

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Nov 2025 $26M $104M City Light Capital · LifeArc Ventures · AlleyCorp · Allumia Ventures ↗
SERIES A✓Equity / VC Jul 2023 $16M $64M City Light Capital · What If Ventures · LifeArc Ventures · Samsung Next ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Affect Therapeutics website traffic

Latest recorded traffic for Affect Therapeutics is 56K monthly website visits, up 80.6% over the last three months. Affect Therapeutics's team grew 27.4% over the past year.

Latest monthly visits56K 3-month web change+80.6% 1-year team growth+27.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

Series A5 investors entered at this stage

  • What If Ventures
  • Artis Ventures
  • LifeArc Ventures
  • Samsung Next
  • Allumia Ventures

Other known investors2 additional known investors

Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States91%
🇨🇴 Colombia7%
🇧🇷 Brazil1%
🇬🇧 United Kingdom1%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Affect Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Affect Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.